Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujay Srinivas

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
South Asian Journal of Cancer|December 5, 2022
An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric CancersPrabhat Bhargava, Sudeep Das, Vikas Ostwal, et al.
Neuroendocrinology|October 5, 2020
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG UptakeVikas Ostwal, Sandip Basu, Prabhat Bhargava, et al.
Acta Oncologica (Stockholm, Sweden)|September 8, 2020
Thromboembolic events in brain tumour patients on bevacizumabGunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, et al.
JAMA Oncology|December 3, 2020
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)Anant Ramaswamy, Vikas Ostwal, Atul Sharma, et al.
South Asian Journal of Cancer|January 9, 2023
The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal CancerOmshree Shetty, Vaibhavi Vengurlekar, Akhil Kapoor, et al.
BMJ Open|June 30, 2021
Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort studyVikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, et al.
Journal of Gastrointestinal Cancer|October 15, 2022
Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pair AnalysisAnant Ramaswamy, Prabhat Bhargava, Sujay Srinivas, et al.
Ecancermedicalscience|February 23, 2023
Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective auditBal Krishna Mishra, Akhil Kapoor, Anuj Gupta, et al.
Medical Oncology (Northwood, London, England)|November 13, 2022
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study)Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, et al.
Ecancermedicalscience|March 8, 2021
Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastomaGunjesh Kumar, Hollis DSouza, Nandini Menon, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
South Asian Journal of Cancer|December 5, 2022
An Analysis of Tolerance and Early Survival Outcomes with Perioperative Modified FLOT in Gastric CancersPrabhat Bhargava, Sudeep Das, Vikas Ostwal, et al.
Neuroendocrinology|October 5, 2020
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG UptakeVikas Ostwal, Sandip Basu, Prabhat Bhargava, et al.
Acta Oncologica (Stockholm, Sweden)|September 8, 2020
Thromboembolic events in brain tumour patients on bevacizumabGunjesh Kumar Singh, Nandini Menon, Monica Madhusing Jadhav, et al.
JAMA Oncology|December 3, 2020
Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)Anant Ramaswamy, Vikas Ostwal, Atul Sharma, et al.
South Asian Journal of Cancer|January 9, 2023
The Prevalence of BRAF, PIK3CA, and RAS Mutations in Indian Patients with Colorectal CancerOmshree Shetty, Vaibhavi Vengurlekar, Akhil Kapoor, et al.
BMJ Open|June 30, 2021
Cancer Aging Research Group (CARG) score in older adults undergoing curative intent chemotherapy: a prospective cohort studyVikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, et al.
Journal of Gastrointestinal Cancer|October 15, 2022
Perioperative Modified FLOT Versus EOX in Locally Advanced Resectable Gastric and Gastro-Oesophageal Junction Adenocarcinoma: Results of a Matched-Pair AnalysisAnant Ramaswamy, Prabhat Bhargava, Sujay Srinivas, et al.
Ecancermedicalscience|February 23, 2023
Neoadjuvant chemotherapy in technically unresectable head and neck cancers: a retrospective auditBal Krishna Mishra, Akhil Kapoor, Anuj Gupta, et al.
Medical Oncology (Northwood, London, England)|November 13, 2022
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study)Vikas Ostwal, Anant Ramaswamy, Prabhat Bhargava, et al.
Ecancermedicalscience|March 8, 2021
Safety and efficacy of bevacizumab biosimilar in recurrent/ progressive glioblastomaGunjesh Kumar, Hollis DSouza, Nandini Menon, et al.
Pageof 5